vidarabine has been researched along with FMR1-Related Primary Ovarian Insufficiency in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Champagne, C; Farrant, P; Taylor, M | 1 |
| Costello, R; Csako, G; Langan, RC; Prieto, PA; Rosenberg, SA; Sherry, RM; White, DE; Wunderlich, J; Yang, JC; Zlott, D | 1 |
2 other study(ies) available for vidarabine and FMR1-Related Primary Ovarian Insufficiency
| Article | Year |
|---|---|
Permanent chemotherapy-induced nonscarring alopecia and premature ovarian failure.
Topics: Adult; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Female; Humans; Primary Ovarian Insufficiency; Thiotepa; Vidarabine | 2015 |
Assessment of ovarian function after preparative chemotherapy and total body radiation for adoptive cell therapy.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Follicle Stimulating Hormone; Humans; Immunotherapy, Adoptive; Middle Aged; Neoplasms; Ovary; Primary Ovarian Insufficiency; Radiotherapy; Retrospective Studies; Treatment Outcome; Vidarabine; Young Adult | 2011 |